Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

被引:1
作者
Kim, Sohyeon [1 ]
Eun, Mi-Yeon [2 ]
Seok, Hung Youl [1 ]
机构
[1] Keimyung Univ, Dongsan Hosp, Dept Neurol, Sch Med, 1035 Dalgubeol Daero, Daegu 42601, South Korea
[2] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea
关键词
CONTROLLED-TRIAL; PSORIASIS; SECUKINUMAB; USABILITY; EFFICACY; SAFETY;
D O I
10.1007/s10072-023-06796-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:2981 / 2982
页数:2
相关论文
共 10 条
[1]   Neurological and psychiatric disorders in psoriasis [J].
Amanat, Man ;
Salehi, Mona ;
Rezaei, Nima .
REVIEWS IN THE NEUROSCIENCES, 2018, 29 (07) :805-813
[2]   Current knowledge on psoriasis and autoimmune diseases [J].
Ayala-Fontanez, Nilmarie ;
Soler, David C. ;
McCormick, Thomas S. .
PSORIASIS-TARGETS AND THERAPY, 2016, 6 :7-32
[3]   Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE) [J].
Blauvelt, A. ;
Prinz, J. C. ;
Gottlieb, A. B. ;
Kingo, K. ;
Sofen, H. ;
Ruer-Mulard, M. ;
Singh, V. ;
Pathan, R. ;
Papavassilis, C. ;
Cooper, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (02) :484-493
[4]   Immunotherapy in myasthenia gravis in the era of biologics [J].
Dalakas, Marinos C. .
NATURE REVIEWS NEUROLOGY, 2019, 15 (02) :113-124
[5]   Paradoxical Reactions to Biologicals in Chronic Inflammatory Systemic Diseases [J].
Kremenevski, Igor ;
Sander, Oliver ;
Sticherling, Michael ;
Raithel, Martin .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (06) :88-+
[6]   Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials [J].
Langley, Richard G. ;
Elewski, Boni E. ;
Lebwohl, Mark ;
Reich, Kristian ;
Griffiths, Christopher E. M. ;
Papp, Kim ;
Puig, Lluis ;
Nakagawa, Hidemi ;
Spelman, Lynda ;
Sigurgeirsson, Bardur ;
Rivas, Enrique ;
Tsai, Tsen-Fang ;
Wasel, Norman ;
Tyring, Stephen ;
Salko, Thomas ;
Hampele, Isabelle ;
Notter, Marianne ;
Karpov, Alexander ;
Helou, Silvia ;
Papavassilis, Charis .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) :326-338
[7]  
Munera-Campos M, 2018, ACTAS DERMO-SIFILOGR, V109, P791, DOI [10.1016/j.adengl.2018.09.012, 10.1016/j.ad.2018.04.003]
[8]   Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor [J].
Papi, Claudia ;
Granata, Giuseppe ;
Galluzzo, Marco ;
Iorio, Raffaele .
NEUROLOGICAL SCIENCES, 2023, 44 (03) :1105-1107
[9]   Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE) [J].
Paul, C. ;
Lacour, J. -P. ;
Tedremets, L. ;
Kreutzer, K. ;
Jazayeri, S. ;
Adams, S. ;
Guindon, C. ;
You, R. ;
Papavassilis, C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) :1082-1090
[10]   Three cases of psoriasis vulgaris associated with myasthenia gravis [J].
Takahashi, Hidetoshi ;
Tsuji, Hitomi ;
Iizuk, Hajime .
JOURNAL OF DERMATOLOGY, 2014, 41 (05) :462-463